Original Research

Treating Acne Scars in Patients With Fitzpatrick Skin Types IV to VI Using the 1450-nm Diode Laser

Individuals with Fitzpatrick skin types IV to VI are becoming a larger proportion of our patient base. Although acne scarring can be difficult to treat in all skin types, it presents a greater challenge in darker skin types due to an increased risk for scarring and postinflammatory hyperpigmentation (PIH). Few studies have focused on infrared laser treatment of acne scarring in darker skin types. In this study, we assess the efficacy and side-effect profile of a 1450-nm diode laser for the treatment of acne scars in participants with Fitzpatrick skin types IV to VI. Our findings show the nonablative 1450-nm diode laser to be safe and effective in improving the appearance of atrophic acne scars in darker skin types. Postinflammatory hyperpigmentation was a common occurrence.


 

Recommended Reading

Tweeting the truth about acne
MDedge Dermatology
Product News: 05 2013
MDedge Dermatology
iPLEDGE and Its Implementation in Dermatology Practices
MDedge Dermatology
Diagnosis and treatment of pediatric acne
MDedge Dermatology
Probiotics in Acne and Rosacea
MDedge Dermatology
A Brief Primer on Acne Therapy for Adolescents With Skin of Color
MDedge Dermatology
Resolution of Radiation-Induced Acneform Eruption Following Treatment With Tretinoin and Minocycline: A Case Report
MDedge Dermatology
Isotretinoin-Induced Skin Fragility in a Teenaged Athlete: A Case Report
MDedge Dermatology
Minocycline-Induced Hyperpigmentation Involving the Oral Mucosa After Short-term Minocycline Use
MDedge Dermatology
Safety First: Fractional Nonablative Laser Resurfacing in Fitzpatrick Skin Types IV to VI
MDedge Dermatology